Ikarian Capital’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.7M | Buy |
|
|||||
|
2025
Q2 | $24.2K | Hold |
|
|||||
|
2025
Q1 | $10.9K | Hold |
|
|||||
|
2024
Q4 | $20.9K | Sell |
|
|||||
|
2024
Q3 | $131K | Hold |
|
|||||
|
2024
Q2 | $121K | Hold |
|
|||||
|
2024
Q1 | $188K | Hold |
|
|||||
|
2023
Q4 | $167K | Hold |
|
|||||
|
2023
Q3 | $121K | Sell |
|
|||||
|
2023
Q2 | $161K | Hold |
|
|||||
|
2023
Q1 | $148K | Hold |
|
|||||
|
2022
Q4 | $229K | Buy |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $588K | Buy |
|
|||||
|
2021
Q4 | $467K | Hold |
|
|||||
|
2021
Q3 | $544K | Sell |
|
|||||
|
2021
Q2 | $9.61M | Buy |
|
|||||
|
2021
Q1 | $10.2M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.88M | Buy |
|